onsemi
ON
$73.23
-4.82%
ON Semiconductor (onsemi) is a vertically integrated supplier of power semiconductors and intelligent sensing products, selling into automotive drivetrains and safety systems, industrial automation, energy infrastructure, and data centers, with the majority of manufacturing performed in-house. It is the world's second-largest power chipmaker and a leading supplier of automotive image sensors, positioning it as a critical enabler of electrification and industrial efficiency rather than a merchant commodity player. The current investor debate centers on the company's $7 billion acquisition of Synaptics, a bold pivot into physical AI and edge inference that management and bulls frame as a long-term growth catalyst while skeptics worry about integration risk, dilution, and the deal's impact on an already cyclical, margin-sensitive business. That debate is playing out against a backdrop of recovering revenue growth (up 9.2% year over year in the latest quarter) but sharply compressed profitability versus 2024 peaks, leaving investors to weigh whether the AI-driven analog upcycle can restore earnings power before the acquisition's costs bite.…
ON
onsemi
$73.23
Related headlines
Investment Opinion: Should I buy ON Today?
The synthesized recommendation is Hold. ON's consensus rating is 'buy' with an average target of $104.67 (45% upside), but the risk/reward is balanced given margin compression and integration risks. The stock is not a screaming buy despite the valuation discount because the earnings recovery is uncertain.
Supporting evidence includes: 1) Forward PE of 15.87x is below peers and the stock's historical PS of 3.71x is well below its 9.8x-22.2x range; 2) Revenue growth of 9.18% YoY shows recovery; 3) FCF yield of 8.0% and current ratio of 4.52 indicate financial strength; 4) Analyst target implies 45% upside. However, gross margin at 38.4% is far from the 45%+ historical level, and TTM net margin is only 2.02%.
Key risks include failure to restore margins, Synaptics integration missteps, and a cyclical downturn. The rating would upgrade to Buy if gross margin sustainably exceeds 40% and revenue growth accelerates above 10%, or downgrade to Sell if gross margin falls below 35% or the Synaptics deal disrupts cash flow. Relative to history and peers, ON appears undervalued on sales and book value, but the discount reflects real fundamental challenges.
Sign up to view all
ON 12-Month Price Forecast
The risk/reward is balanced. Valuation is attractive on sales and book value, and cash generation is robust, but margin recovery is the key swing factor. The Synaptics deal adds long-term growth potential but near-term uncertainty. I would upgrade to bullish if gross margins show sustained improvement above 40% and revenue growth accelerates; downgrade to bearish if margins stagnate or integration issues emerge.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on onsemi's 12-month outlook, with a consensus price target around $102.81 and implied upside of +40.4% versus the current price.
Average Target
$102.81
0 analysts
Implied Upside
+40.4%
vs. current price
Analyst Count
—
covering this stock
Price Range
$75 - $137
Analyst target range
Coverage is robust with 27 analysts, and the consensus recommendation is "buy" with a mean rating of 2.10 (where lower is more bullish), reflecting a moderately constructive but not euphoric stance. The average target price of $104.67 implies roughly 45.3% upside from the current $72.02, a wide gap that signals analysts believe the recent selloff has overshot fundamentals. Consensus estimates call for EPS of about $9.00 (range $8.67-$9.46) on revenue of roughly $10.81 billion, which underpins the bullish case that earnings will normalize sharply from current depressed levels.
Target dispersion is very wide, spanning $75.00 to $150.00 — a 2x spread that signals high uncertainty about the Synaptics integration, the pace of the analog recovery, and AI-driven demand. The $150 high target assumes successful execution on physical AI and edge inference, margin recovery toward historical mid-40s gross margins, and multiple expansion as the AI narrative gains traction; the $75 low target — barely above the current price — prices in continued margin compression, integration missteps, and a muted cyclical recovery. Recent institutional actions skew cautious: the September 2026 updates from Truist, Stifel, Rosenblatt, and Cantor Fitzgerald were all Hold/Neutral reiterations, with only Needham (Buy), Wells Fargo (Overweight), and Mizuho (Outperform) maintaining bullish ratings, indicating analysts are largely in wait-and-see mode pending evidence that the turnaround is real rather than upgrading into the dip.
Bulls vs Bears: ON Investment Factors
The bull case rests on historically cheap valuation (PS 3.71x vs. historical 9.8x-22.2x), strong FCF (8% yield), a healthy balance sheet, and analyst targets implying 45% upside, supported by early signs of revenue recovery (+9.2% YoY) and a return to profitability. The bear case centers on margin compression (gross margin down from 45.2% to 38.4%), integration risk from the $7 billion Synaptics deal, and extreme volatility (beta 2.05). Currently, the bear evidence appears stronger given the multi-quarter margin deterioration and cautious analyst stance, but the valuation discount and cash generation provide a counterbalance. The single most important tension is whether gross margins can recover toward mid-40s as forward estimates assume; if they do, the stock is significantly undervalued, but if they stagnate, the recent rally may fade.
Bullish
- Deep valuation discount to history: At $72.02, ON trades at a PS ratio of 3.71x and P/B of 2.90x, far below its historical PS range of 9.8x-22.2x and P/B range of 3.0x-6.4x. This suggests the market has priced in significant pessimism, offering a margin of safety if fundamentals normalize.
- Strong free cash flow and balance sheet: TTM free cash flow of $1.77 billion yields 8.0% of the $22.26 billion market cap, while a current ratio of 4.52 and debt-to-equity of 0.45 underscore a conservatively leveraged balance sheet. Q2 alone generated $425.4 million in FCF, funding $344.8 million in buybacks and $1.47 billion in debt retirement.
- Analyst consensus sees 45% upside: With 27 analysts covering, the consensus rating is 'buy' (mean 2.10) and the average target price of $104.67 implies 45.3% upside from $72.02. The high target of $150 reflects optimism around the Synaptics-driven AI narrative and margin recovery.
- Revenue growth reaccelerating sequentially: Q2 2026 revenue of $1.6035 billion grew 9.18% YoY and 5.96% QoQ, marking the second consecutive quarter of sequential growth. This suggests the inventory correction is easing and the analog upcycle may be underway.
Bearish
- Margin compression from historical peaks: Gross margin has fallen from 45.2% in Q4 2024 to 38.4% in Q2 2026, and TTM gross margin is just 33.1%. This reflects underutilization and pricing pressure, and a return to mid-40s margins is uncertain.
- Synaptics integration risk and dilution: The $7 billion acquisition of Synaptics is a bold pivot into physical AI, but skeptics worry about integration challenges, dilution, and the deal's impact on an already cyclical, margin-sensitive business. The stock's 50.27% max drawdown partly reflects this overhang.
- Extremely high beta and volatility: With a beta of 2.052, ON is roughly twice as volatile as the market, evidenced by the June-to-July collapse from $118.74 to $90.65 and the 16.6% slide from $86.31 to $72.02 in eight sessions. This amplifies downside risk in adverse scenarios.
- Weak trailing profitability and returns: TTM net margin is only 2.02% and operating margin 1.40%, with ROE of 1.58% and ROA of 6.75%. The trailing PE of 186.7x is meaningless, but the depressed earnings base highlights the risk if the recovery stalls.
ON Technical Analysis
ON is in a volatile, range-bound consolidation with a distinctly negative intermediate tilt despite a positive long-term record: the stock is up 35.96% over the past year but sits at $72.02, only 30.6% of the way up its 52-week range of $44.56 to $134.92, having surrendered roughly half its value from the June peak of $133.93. That positioning near the lower third of the annual range signals the stock is neither a clean momentum leader nor a deep-value falling knife, but rather a name that has given back a large portion of a powerful rally and is now searching for a base. The 50.27% maximum drawdown underscores how violently sentiment has swung around the Synaptics deal and the semiconductor cycle.
Short-term momentum is diverging sharply from the longer-term trend. The stock has rebounded 8.14% over the past month, outperforming the S&P 500 by 6.92 percentage points, yet it remains down 17.57% over three months and 13.24% over six months, with relative strength of -20.26 and -20.72 versus SPY over those windows. This pattern — a strong one-month bounce inside a three-month downtrend — is characteristic of a mean-reversion rally or oversold bounce rather than a confirmed trend reversal, especially since the bounce has already stalled, with the stock falling from $86.31 on October 6 to $72.02 by October 16 (a 16.6% slide in eight sessions) on elevated volume of 9.22 million shares. The year-to-date gain of 27.02% still outpaces SPY's 11.93%, so the longer-term relative strength (+15.09 YTD) remains intact even as the intermediate trend deteriorates.
Key technical levels are well defined: support sits at the 52-week low of $44.56, with an intermediate floor near the September low of $66.60, while resistance is anchored at the 52-week high of $134.92 and, more immediately, the $86-$87 area where the October rally failed. A decisive break below $66.60 would confirm the downtrend and open the door toward the $44.56 low, whereas reclaiming $86 would signal the consolidation is resolving higher. With a beta of 2.052, ON is roughly twice as volatile as the market, meaning position sizing should be materially smaller than a market-beta equivalent and stop-losses should be set wider to avoid noise-driven exits — a 2x beta stock can move 10% in days, as the June-to-July collapse from $118.74 to $90.65 demonstrated.
Beta
2.05
2.05x market volatility
Max Drawdown
-50.3%
Largest decline past year
52-Week Range
$45-$135
Price range past year
Annual Return
+41.0%
Cumulative gain past year
| Period | ON Return | S&P 500 |
|---|---|---|
| 1m | -0.5% | -1.2% |
| 3m | -15.6% | +3.4% |
| 6m | -25.6% | +7.0% |
| 1y | +41.0% | +14.4% |
| ytd | +29.2% | +12.0% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
ON Fundamental Analysis
Revenue is on a modest recovery path after a pronounced cyclical trough. The latest quarter (ended July 3, 2026) delivered $1.6035 billion in revenue, up 9.18% year over year from $1.4687 billion, and up 5.96% sequentially from Q1's $1.5133 billion, marking a second consecutive quarter of sequential growth after Q4 2025's $1.5301 billion. The segment mix shows Power Solutions Group as the largest contributor at $829.0 million, followed by Analog Solutions Group at $545.7 million and Intelligent Sensing Group at $228.8 million, with power and analog — the businesses most levered to EV, industrial, and data-center demand — carrying roughly 86% of revenue. The trajectory implies the inventory correction that crushed 2025 results is easing, but growth in the high-single digits is a far cry from the double-digit-plus expansion investors enjoyed in 2022-2023, so the investment case now hinges on the Synaptics-driven AI narrative rather than organic acceleration.
Profitability has recovered from a deeply loss-making Q1 but remains well below historical peaks. Q2 2026 net income was $226.8 million (14.1% net margin) on a 38.43% gross margin and 16.13% operating margin, a dramatic swing from Q1's net loss of $33.4 million (-2.2% margin) and negative 3.53% operating margin, which itself followed a brutal Q1 2025 loss of $486.1 million tied to a 20.3% gross margin. The concerning signal is the multi-quarter margin trajectory: gross margin has fallen from 45.2% in Q4 2024 to 38.4% in Q2 2026, and the trailing twelve-month net margin is just 2.02% with a trailing operating margin of 1.40%, reflecting the drag of the loss quarters. For a power semiconductor leader that historically ran 45%+ gross margins, the current 33.1% TTM gross margin suggests meaningful underutilization and pricing pressure, and the path back toward mid-40s margins is the key fundamental catalyst to watch.
Balance sheet strength is the standout feature of the fundamental picture. The current ratio of 4.52 and debt-to-equity of 0.45 indicate a conservatively levered, highly liquid balance sheet, and the company generated $1.7725 billion in trailing twelve-month free cash flow against a $22.26 billion market cap — a roughly 8.0% FCF yield that is unusually attractive for a semiconductor name. Q2 operating cash flow of $459.7 million against just $34.3 million of capex produced $425.4 million of free cash flow, and the company returned capital aggressively via $344.8 million of buybacks in the quarter while retiring $1.4737 billion of debt. However, ROE of just 1.58% and ROA of 6.75% reveal how much the earnings base has shrunk, and the PEG ratio of -2.03 is meaningless given the depressed earnings — the cash generation, not the accounting returns, is what underpins the financial risk profile here.
Quarterly Revenue
$1.6B
2026-07
Revenue YoY Growth
+9.2%
YoY Comparison
Gross Margin
38.4%
Latest Quarter
Free Cash Flow
$1.8B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is ON Overvalued?
Because trailing net income is positive but negligible (TTM EPS of $0.0054), the trailing PE of 186.7x is economically meaningless and I therefore lead with the forward PE of 15.87x, which is the metric that actually reflects the market's view of normalized earnings power. The enormous gap between the 186.7x trailing and 15.87x forward multiple implies the market expects earnings to multiply roughly twelve-fold over the next year, consistent with consensus EPS estimates of about $9.00 versus the near-zero trailing figure — a recovery assumption that is aggressive but supported by the Q2 annualized run-rate of roughly $2.24 in EPS. The PS ratio of 3.71x and EV/Sales of 4.77x provide a cleaner cross-check on a business with volatile earnings.
On a peer basis, the forward PE of 15.87x is modest for a semiconductor company with AI and electrification exposure, and the PS ratio of 3.71x sits well below the company's own historical norms, suggesting the stock is not expensive on sales-based measures. The EV/EBITDA of 26.54x looks rich, but that is an artifact of depressed trailing EBITDA (the Q1 2026 EBITDA was actually negative at -$46.7 million), so it overstates the true multiple on normalized profitability. Relative to large-cap analog and power peers that typically trade in the high-teens to low-20s forward PE range during upcycles, ON's 15.87x forward multiple implies a discount that is arguably unjustified given its second-largest-global-power-chipmaker position and 8% FCF yield, though the Synaptics integration overhang and margin compression explain part of the gap.
Historical context is instructive: ON's PS ratio has ranged from roughly 9.8x (Q1 2025) to 22.2x (Q2 2026) over the past several years, and the current 3.71x reading is dramatically below that entire band — a level last seen before the 2021-2022 semiconductor boom. Similarly, the price-to-book of 2.90x compares favorably to historical readings of 3.0x-6.4x from 2021 through 2024, placing the stock near the bottom of its own valuation range. This compression reflects genuine fundamental deterioration (margins and returns at multi-year lows) rather than pure sentiment, so while the stock screens as historically cheap, the market is pricing in skepticism about the durability of the earnings recovery and the wisdom of the $7 billion Synaptics bet — a setup where the valuation offers upside only if margins normalize as the forward estimates assume.
PE
186.7x
Latest Quarter
vs. Historical
High-End
5-Year PE Range 11x~22x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
26.5x
Enterprise Value Multiple
Investment Risk Disclosure
Financial and operational risks are significant. The company's gross margin has compressed from 45.2% in Q4 2024 to 38.4% in Q2 2026, and TTM gross margin is just 33.1%, reflecting underutilization and pricing pressure. TTM net margin is a thin 2.02% and ROE is only 1.58%, leaving little cushion if the recovery falters. Additionally, the $7 billion Synaptics acquisition could strain the balance sheet (debt-to-equity currently 0.45) and dilute earnings, while integration risks may divert management attention from the core business.
Market and competitive risks are elevated. ON trades at a forward PE of 15.87x, which is below analog peers in the high-teens to low-20s, but the discount may be justified given margin compression and integration overhang. The stock's beta of 2.052 means it is highly sensitive to market rotations; a sector rotation away from semiconductors could amplify losses. Recent news highlights AI-driven demand in analog chips (e.g., Texas Instruments' data center sales doubling), but ON's exposure to automotive and industrial markets may lag the data center boom. Analyst actions have been cautious, with several Hold reiterations, indicating limited near-term catalysts.
The worst-case scenario involves a double-dip in the semiconductor cycle, failure to integrate Synaptics, and margins stagnating near 35%. In that case, the stock could retest its 52-week low of $44.56, representing a 38% decline from $72.02. The analyst low target of $75 is only 4% above the current price, suggesting limited downside protection from analysts. Given the 50.27% max drawdown over the past year, investors should be prepared for significant volatility.
FAQ
The biggest risk is margin compression: gross margin has fallen from 45.2% to 38.4%, and a failure to recover would undermine the earnings recovery thesis. Second, integration risk from the $7 billion Synaptics acquisition could lead to dilution, writedowns, or management distraction. Third, the stock's high beta of 2.05 makes it vulnerable to market downturns and sector rotations. Fourth, cyclical demand in automotive and industrial markets could weaken, especially if a recession hits. Finally, analyst caution (recent Hold reiterations) suggests limited near-term catalysts.
Our 12-month forecast has a base case (50% probability) of $90-$110, assuming gradual margin recovery to 40-42% and revenue growth of 8-10%. The bull case (25%) targets $130-$150 on successful Synaptics integration and margin expansion to mid-40s. The bear case (25%) sees $45-$75 if margins stagnate or a cyclical downturn occurs. The most likely scenario is the base case, hinging on gross margin improvement. Analyst average target of $104.67 aligns with our base case.
ON appears undervalued on most metrics. The PS ratio of 3.71x is drastically below its historical range of 9.8x-22.2x, and P/B of 2.90x is near the low end of its 3.0x-6.4x range. The forward PE of 15.87x is below analog peers in the high-teens to low-20s. However, the trailing PE of 186.7x is meaningless due to depressed earnings. The market is pricing in skepticism about margin recovery and the Synaptics deal, implying that if earnings normalize as consensus expects (EPS ~$9), the stock is cheap. But if margins stagnate, the valuation could remain depressed.
ON offers a compelling risk/reward for value-oriented investors with a long-term view. The stock trades at a forward PE of 15.87x and PS of 3.71x, well below historical norms, while analysts see 45% upside to their average target of $104.67. However, the 38.4% gross margin is far from the 45%+ peak, and the Synaptics integration adds uncertainty. The 8% FCF yield and strong balance sheet provide downside support. It is a good buy for patient investors who believe margins will recover, but near-term volatility (beta 2.05) could test conviction.
ON is better suited for long-term investors with a horizon of at least 2-3 years. The stock's high beta (2.05) and cyclicality make short-term trading risky, as evidenced by the 50% drawdown in the past year. The Synaptics acquisition and margin recovery will take time to play out. However, the strong FCF generation and valuation discount provide a margin of safety for patient capital. Short-term traders might exploit volatility around earnings, but timing is difficult. A minimum holding period of 18-24 months is recommended to ride out the cycle.